Literature DB >> 8372774

Gliomatosis cerebri: comparison of MR and CT features.

Y M Shin1, K H Chang, M H Han, N H Myung, J G Chi, S H Cha, M C Han.   

Abstract

OBJECTIVE: Gliomatosis cerebri is a diffuse infiltrative glial neoplasm frequently involving both cerebral hemispheres. Diagnosis and evaluation of its extent with CT are known to be difficult. The purpose of this study was to compare the MR and CT findings in gliomatosis cerebri.
MATERIALS AND METHODS: MR images of nine patients were reviewed retrospectively and compared with CT scans. Pathology was determined by open or stereotaxic biopsy. The MR images included sagittal T1-weighted, axial proton density-weighted, and T2-weighted images. Contrast material was administered in seven patients. Unenhanced and enhanced CT scans were obtained in eight patients.
RESULTS: On proton density-weighted and T2-weighted MR images, the most common findings were poorly defined bilateral areas of diffuse high signal intensity in the cerebral hemisphere. On T1-weighted images, the lesions were isointense to hypointense compared with normal brain. Enhanced T1-weighted images showed focal parenchymal enhancement in three patients and meningeal enhancement in one. On CT scans, the lesions showed poorly defined areas of subtle low density or isodensity, and appeared much smaller than those on T2-weighted MR images. Enhancement was seen in only one case. The extent of disease was evaluated much better on T2-weighted MR images than on T1-weighted MR images and CT scans.
CONCLUSION: In gliomatosis cerebri, MR imaging is more sensitive than CT for detecting lesions and shows the extent of disease better than CT does. Accordingly, MR imaging should be used as a primary imaging study in the evaluation of gliomatosis cerebri.

Entities:  

Mesh:

Year:  1993        PMID: 8372774     DOI: 10.2214/ajr.161.4.8372774

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

1.  Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.

Authors:  Stanley Yang; Stephan Wetzel; M Law; D Zagzag; Soonmee Cha
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  Gliomatosis cerebri: a review.

Authors:  Roberta Rudà; Luca Bertero; Marc Sanson
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

3.  Histological and genetic diagnosis of gliomatosis cerebri: case report.

Authors:  S M Yamada; Y Hayashi; H Takahashi; A Teramoto; K Matsumoto; S Yamada
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

4.  MRI features of gliomatosis cerebri in a dog.

Authors:  Paula Martin-Vaquero; Ronaldo C da Costa; Kendra E Wolk; Christopher Premanandan; Michael J Oglesbee
Journal:  Vet Radiol Ultrasound       Date:  2012 Mar-Apr       Impact factor: 1.363

5.  MR spectroscopy in gliomatosis cerebri.

Authors:  M Bendszus; M Warmuth-Metz; R Klein; R Burger; C Schichor; J C Tonn; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

6.  Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.

Authors:  Tomoo Inoue; Toshihiro Kumabe; Masayuki Kanamori; Yukihiko Sonoda; Mika Watanabe; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2011-02-08       Impact factor: 3.042

7.  Gliomatosis cerebri mimicking a metastatic breast cancer: fatal outcome.

Authors:  A Iglesias; M García; J San Millán; C Villanueva; G Fraile; M Serrano
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

8.  Impact of adjuvant chemotherapy for gliomatosis cerebri.

Authors:  Doo-Sik Kong; Sung Tae Kim; Jung-Il Lee; Yeon-Lim Suh; Do Hoon Lim; Won Seog Kim; Ki-Hoon Kwon; Kwan Park; Jong Hyun Kim; Do-Hyun Nam
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

9.  Presentation patterns and outcome of gliomatosis cerebri.

Authors:  Gustavo G Rajz; Dvora Nass; Elisa Talianski; Raphael Pfeffer; Roberto Spiegelmann; Zvi R Cohen
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

10.  Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.

Authors:  N Sato; T Inoue; K Tomiyoshi; J Aoki; N Oriuchi; A Takahashi; T Otani; H Kurihara; T Sasaki; K Endo
Journal:  Neuroradiology       Date:  2003-09-13       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.